Soros buys big into Dendreon
Some corners will probably say his aim it to blow-up US healthcare cost (it doesn’t need Soros for that, but anyway)..
What to buy? Gamble on biotech stocks
The regulatory approval process for new drugs is Byzantine, lengthy, and unpredictable. Single stocks are, for outsiders at least (even insiders can be surprised), almost pure bets. But one can […]
Dendreon’s Provenge blockbuster opportunity
We’re a bit frustrated, as we the things we follow had quite a run, but now we don’t trust the markets anymore, to be honest. We’re looking for things that […]
Dendreon’s dramatic day
Now here is real drama, both on the medical front and in the markets. Dendreon (DNDN), you have probably heared about it. The stock was all over the place today […]